

NEWS
-
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
-
Upcoming Conference Presentation at EANM’25(PeptiDream Inc)
-
Launch of “onti dandori” – A Scheduling Module for the “onti” System for Nuclear Medicine Exposure Dose Management
-
Bridgea DISPENSER Now Equipped with Liquid Collection Function — Enhancing Operational Efficiency and Safety in Radiopharmaceutical Preparation
-
PDRadiopharma Receives Approval for Expanded Indication of Raiatt MIBG-I131 for Neuroblastoma